Provide a valuable resource to your clients or customers by linking to this resource page. Just place the following link on your website.
Scleromalacia is thinning and weakening of the sclera, often from chronic inflammatory damage. A well-known form is scleromalacia perforans, where scleral melt occurs with little to no redness or pain. The sclera can look bluish because underlying darker tissue shows through the thin wall. Although symptoms can feel mild, the eye becomes fragile and injury risk rises.
read more about scleromalacia ...Scleromalacia is most strongly linked with long-standing rheumatoid arthritis, especially in older adults with chronic disease. It can also be associated with other systemic inflammatory conditions that affect small blood vessels. The process involves gradual tissue loss, and in scleromalacia perforans the surface can look quiet despite ongoing damage. Prior episodes of scleritis can also leave areas of thinning. Because the cause is often systemic, management frequently involves coordination with the clinician managing the underlying disease.
Many people have few symptoms early, which is why the condition can go unnoticed. The sclera can develop a gray, yellow, or bluish discoloration where it is thinning. Some people notice mild irritation or a foreign-body sensation, especially if the overlying surface becomes irregular. Vision changes can occur if complications develop or if nearby structures become involved. Any sudden pain, new bulge, or rapid vision change needs urgent evaluation because a fragile sclera can perforate.
Diagnosis is made with a slit-lamp exam that shows localized thinning and loss of normal scleral tissue. The eye can appear quiet with minimal redness, which helps distinguish scleromalacia perforans from painful inflammatory scleritis. The clinician checks adjacent tissues, since corneal thinning or uveitis can coexist in some patients. Systemic history matters, so evaluation often includes questions about rheumatoid arthritis and other autoimmune symptoms. Documentation with photos or imaging helps monitor changes over time.
Treatment focuses on protecting the eye and controlling the underlying systemic inflammation. Rheumatology-guided systemic therapy is often part of the plan when active autoimmune disease is driving tissue loss. Eye protection steps include avoiding rubbing and using protective eyewear in higher-risk settings, since minor trauma can cause serious injury. Lubricating drops can help surface comfort, but they do not stop scleral melt. When thinning becomes advanced, surgical reinforcement such as patch grafting can reduce perforation risk.
It is often described as necrotizing anterior scleritis without obvious inflammation. The sclera melts and thins, but the eye can look white and quiet rather than red and painful. Because the mechanism is still tissue loss, it carries serious risk even when symptoms feel mild. An eye doctor can confirm the pattern during exam.
Not always. Scleromalacia perforans is known for minimal pain and redness, which can delay diagnosis. Other forms of scleral thinning can have discomfort if adjacent inflammation is present. Any new pain deserves evaluation because it can signal progression or a new complication. Regular monitoring is a safer approach than waiting for symptoms.
Yes. Severe thinning leaves the sclera fragile, and even minor trauma can cause a rupture or perforation. The risk rises when thinning exposes darker underlying tissue or forms a localized bulge. Protective habits and timely medical care reduce risk. Surgical reinforcement is considered when the wall becomes dangerously thin.
Scleromalacia Perforans. EyeWiki. https://eyewiki.org/Scleromalacia_Perforans. Date Accessed February 4, 2026.
Senile Scleral Plaque. EyeWiki. https://eyewiki.org/Senile_Scleral_Plaque. Date Accessed February 4, 2026.
Scleritis - StatPearls - NCBI Bookshelf. StatPearls (NCBI Bookshelf). https://www.ncbi.nlm.nih.gov/books/NBK499944/. Date Accessed February 4, 2026.
Scleral thinning: Causes, diagnosis, and management. PubMed. https://pubmed.ncbi.nlm.nih.gov/36716993/. Date Accessed February 4, 2026.
Scleritis: What It Is, Causes, Symptoms & Treatment. Cleveland Clinic. https://my.clevelandclinic.org/health/diseases/24975-scleritis. Date Accessed February 4, 2026.